Navigation Links
iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product
Date:1/22/2008

offers a comprehensive range of high-performance, upgradeable CAD systems for the high, mid and low volume mammography markets. iCAD is entrusted with the task of early cancer detection by over 1500 women's healthcare centers worldwide. For more information, call +1 877 iCADnow or visit http://www.icadmed.com.
For iCAD, contact Darlene Deptula-Hicks, EVP and CFO at 603-882-5200 x7944 or

via email at ddeptula@icadmed.com For iCAD Investor Relations, contact Anne Marie Fields of Lippert/Heilshorn &

Associates at 212-838-3777 x6604 or via email at icad@lhai.com

For iCAD Public Relations, contact Wendy Ryan of Schwartz Communications at

781-684-0770 or via email at icad@schwartz-pr.com

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995:

Certain statements contained in this News Release constitute "forward- looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited to, the risks of uncertainty of patent protection, the impact of supply and manufacturing constraints or difficulties, product market acceptance, possible technological obsolescence, increased competition, customer concentration and other risks detailed in the Company's filings with the Securities and Exchange Commission. The words "believe", "demonstrate", "intend", "expect", "estimate", "anticipate", "likely", and similar expressions identify forward- looking statements. Readers are cau
'/>"/>

SOURCE iCAD, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... July 29, 2014 Regado Biosciences, Inc. (Nasdaq: ... the Phase 3 clinical development of Revolixys™ Kit (previously ... system, today announced that it will hold a conference ... 2014, at 8:30 a.m. EDT to discuss its second ... Interested participants and investors may access the conference call ...
(Date:7/29/2014)... , July 29, 2014  Alexza Pharmaceuticals, Inc. ... is participating in two healthcare conferences during the third ... the Morgan Stanley Global Healthcare 2014 Conference.  Alexza,s corporate ... Conference.  The details on each event are below: ... August 11, 2014 in Boston , ...
(Date:7/29/2014)... , July 29, 2014  Landauer, Inc. (NYSE: ... and environmental radiation measurement and monitoring, outsourced medical physics ... financial results for the fiscal third quarter 2014 after ... The Company will host a conference call ... a.m. Central Time (10 a.m. Eastern Time). Investors may ...
Breaking Medicine Technology:Regado Biosciences to Provide Second Quarter 2014 Financial Results and Corporate Highlights 2Regado Biosciences to Provide Second Quarter 2014 Financial Results and Corporate Highlights 3Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences 2Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences 3Landauer, Inc. Sets Date and Time for Announcement of Fiscal Third Quarter 2014 Results 2
... Five Posters Scheduled for the 2008 Annual Meeting ... Vision and Ophthalmology (ARVO), IRVINE, Calif., Feb. ... announced today the acceptance of an abstract,describing the ... 0.09% therapy in combination with Lucentis(R) (ranibizumab,injection) in ...
... Flawed policies and,bad decisions at the FDA have contributed ... now take an average of one billion dollars and,require ... prevented the,availability of many promising treatment options, resulting in ... cost of medical,treatment in the United States., It,s ...
Cached Medicine Technology:ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R) 2ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R) 3ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R) 4ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R) 5Cancer Cure Coalition Proposes Major Changes at the FDA 2Cancer Cure Coalition Proposes Major Changes at the FDA 3
(Date:7/29/2014)... SC (PRWEB) July 29, 2014 During his ... L. Bruce, DMD & Associates, has had a steady stream ... about dentistry. These students have now gone on to dental ... practices, proving that the shadowing program helps college students find ... Dr. Bruce has given them the chance to see a ...
(Date:7/29/2014)... of Medicine researchers have made an important advancement ... potentially deadly tick-transmitted disease, human granulocytic anaplasmosis (HGA). ... seen a steady rise in the incidence of ... making the need for a vaccine critical. Successful ... to prevent disease, and the VCU team has ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Bret ... LLP ’s Boise office, has been appointed to the ... Greater Idaho. , Busacker is an experienced business attorney ... matters. He advises clients on a wide spectrum of ... plan administration, compliance, and governance concerns. His clients include ...
(Date:7/29/2014)... cancer is to surgically remove the tumor. The Achilles ... may fail to extract the entire tumor, leading to ... at the University of Pennsylvania have established a new ... the patient, increasing the likelihood of a positive outcome. ... in cancerous tissues much more so than normal tissues. ...
(Date:7/29/2014)... Helping people recover from the debilitating effects ... requires deep knowledge of neurophysiology as well as effective ... outcomes has been the primary focus of research by ... joined the NJIT faculty more than a decade ago. ... funding from sources such as the National Institutes of ...
Breaking Medicine News(10 mins):Health News:Arthur Bruce Dental Helps College Students 2Health News:Researchers take steps toward development of a vaccine against tick-transmitted disease 2Health News:Researchers take steps toward development of a vaccine against tick-transmitted disease 3Health News:Holland & Hart Partner Brett Busacker Appointed to Board of Directors for American Red Cross of Greater Idaho 2Health News:Penn team makes cancer glow to improve surgical outcomes 2Health News:Penn team makes cancer glow to improve surgical outcomes 3Health News:Continuing the Quest for Better Stroke Therapies 2Health News:Continuing the Quest for Better Stroke Therapies 3Health News:Continuing the Quest for Better Stroke Therapies 4
... ... accident, persuades jury that defendants were 100% responsible for client’s accident. , ... New York (Lexis Nexis) November 30, 2009 -- ... who was injured at a New York City construction site in 2004., , ,The case, ...
... , CLEVELAND, Ohio, November 30 ... simulation systems, in collaboration,with GORE Medical Products will be ... at the upcoming ICCA Meeting in Frankfurt,Germany. , ... the world,s first medical,simulator to enable clinicians to create ...
... CHICAGO Elastography is an effective, convenient technique ... cancerous breast lesions from benign results, according to ... meeting of the Radiological Society of North America ... often use ultrasound to obtain additional information. However, ...
... ... Dentistry (AGD) announces that Aria Irvani, DDS, of Orange county CA, received the Mastership ... dental education.,To accomplish this, Dr. Irvani completed 1,100 hours of approved continuing dental education ... techniques. , ...
... For well-being, a $1,300 round of treatment equals a ... (HealthDay News) -- Psychological therapy may be much more ... or winning a lottery prize, suggests an English study. ... provided information about their mental well-being and found that ...
... Nov. 28 Get ready for advanced visualization to ... Siemens introduces syngo. via(1) at ... North America (RSNA) from November 29 to December 3 at McCormick Place ... syngo. via , Siemens, new imaging ...
Cached Medicine News:Health News:Raphaelson & Levine Secures $1.1 Million Verdict for Victim of New York Construction Accident 2Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 2Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 3Health News:Elastography reduces unnecessary breast biopsies 2Health News:Orange County Dentist Honored by The Academy of General Dentistry 2Health News:Psychotherapy Can Boost Happiness More Than Money: Study 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 4Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 5
... German Craftsmanship have produced ... in the world. Ocutek ... to you! Only holders ... certificate, which requires and ...
... German Craftsmanship have produced ... in the world. Ocutek ... to you! Only holders ... certificate, which requires and ...
... are constructed of a patented ... polyvinyl acetal sponge. Each device ... to both surgeon and patient, ... firm enough to gently manipulate ...
... Merocel Ophthalmic Products provide ... fiber free products for ... safe cleaning of fine ... Merocel material is highly ...
Medicine Products: